Globus Medical ROE 2010-2025 | GMED
Current and historical return on equity (ROE) values for Globus Medical (GMED) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| Globus Medical ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2025-03-31 | $0.19B | $4.09B | 4.56% |
| 2024-12-31 | $0.10B | $4.18B | 2.58% |
| 2024-09-30 | $0.09B | $4.07B | 2.31% |
| 2024-06-30 | $0.04B | $3.98B | 1.02% |
| 2024-03-31 | $0.07B | $3.92B | 1.90% |
| 2023-12-31 | $0.12B | $4.00B | 4.07% |
| 2023-09-30 | $0.16B | $4.19B | 6.36% |
| 2023-06-30 | $0.20B | $1.99B | 10.87% |
| 2023-03-31 | $0.20B | $1.92B | 11.13% |
| 2022-12-31 | $0.19B | $1.85B | 10.71% |
| 2022-09-30 | $0.16B | $1.76B | 8.87% |
| 2022-06-30 | $0.16B | $1.70B | 8.93% |
| 2022-03-31 | $0.14B | $1.79B | 8.25% |
| 2021-12-31 | $0.15B | $1.74B | 8.95% |
| 2021-09-30 | $0.19B | $1.72B | 11.64% |
| 2021-06-30 | $0.18B | $1.64B | 12.02% |
| 2021-03-31 | $0.12B | $1.56B | 8.31% |
| 2020-12-31 | $0.10B | $1.51B | 7.26% |
| 2020-09-30 | $0.10B | $1.42B | 6.89% |
| 2020-06-30 | $0.09B | $1.34B | 6.54% |
| 2020-03-31 | $0.15B | $1.36B | 10.98% |
| 2019-12-31 | $0.16B | $1.40B | 11.77% |
| 2019-09-30 | $0.15B | $1.34B | 11.56% |
| 2019-06-30 | $0.14B | $1.29B | 11.79% |
| 2019-03-31 | $0.15B | $1.24B | 12.87% |
| 2018-12-31 | $0.16B | $1.19B | 14.11% |
| 2018-09-30 | $0.14B | $1.14B | 13.61% |
| 2018-06-30 | $0.14B | $1.10B | 13.41% |
| 2018-03-31 | $0.12B | $1.03B | 12.41% |
| 2017-12-31 | $0.11B | $0.97B | 11.75% |
| 2017-09-30 | $0.11B | $0.94B | 12.20% |
| 2017-06-30 | $0.11B | $0.91B | 12.65% |
| 2017-03-31 | $0.11B | $0.87B | 12.76% |
| 2016-12-31 | $0.10B | $0.83B | 13.12% |
| 2016-09-30 | $0.12B | $0.81B | 15.46% |
| 2016-06-30 | $0.12B | $0.78B | 16.18% |
| 2016-03-31 | $0.12B | $0.75B | 16.68% |
| 2015-12-31 | $0.11B | $0.72B | 17.08% |
| 2015-09-30 | $0.10B | $0.67B | 16.38% |
| 2015-06-30 | $0.10B | $0.64B | 16.69% |
| 2015-03-31 | $0.10B | $0.61B | 17.01% |
| 2014-12-31 | $0.09B | $0.59B | 17.15% |
| 2014-09-30 | $0.09B | $0.55B | 16.73% |
| 2014-06-30 | $0.08B | $0.53B | 17.03% |
| 2014-03-31 | $0.07B | $0.50B | 14.97% |
| 2013-12-31 | $0.07B | $0.47B | 15.54% |
| 2013-09-30 | $0.07B | $0.45B | 16.34% |
| 2013-06-30 | $0.06B | $0.42B | 16.19% |
| 2013-03-31 | $0.08B | $0.41B | 20.53% |
| 2012-12-31 | $0.07B | $0.39B | 21.53% |
| 2012-09-30 | $0.07B | $0.36B | 21.10% |
| 2012-06-30 | $0.07B | $0.32B | 30.02% |
| 2012-03-31 | $0.06B | $0.30B | 42.47% |
| 2011-12-31 | $0.06B | $0.28B | 79.43% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $8.153B | $2.519B |
| Globus Medical, Inc. is a medical device company that develops and commercializes healthcare solutions for patients with musculoskeletal disorders. The company currently has its sales operations distributed across counties world wide. Its Musculoskeletal Solutions consist primarily of implantable devices, biologics, accessories, and unique surgical instruments, used in an expansive range of spinal, orthopedic and neurosurgical procedures. The spine products address the vast majority of conditions affecting the spine including degenerative conditions, deformity, tumors and trauma. Enabling Technologies are designed to enhance a surgeon's capabilities and streamline the complicated surgical procedures to be safer, less invasive, accurate and more reproducible to improve patient care and reduce radiation exposure for both patient and caregiver. The technology contains imaging, navigation and robotic assisted surgery solutions. It acquired all assets of StelKast, Inc. and Finnish engineering company Synoste Oy. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $196.080B | 85.88 |
| Thermo Fisher Scientific (TMO) | United States | $150.348B | 18.19 |
| Edwards Lifesciences (EW) | United States | $44.640B | 29.27 |
| Alcon (ALC) | Switzerland | $43.179B | 29.18 |
| IDEXX Laboratories (IDXX) | United States | $40.281B | 46.29 |
| DexCom (DXCM) | United States | $33.286B | 51.45 |
| STERIS (STE) | Ireland | $24.202B | 26.69 |
| IQVIA Holdings (IQV) | United States | $23.751B | 13.30 |
| Mettler-Toledo (MTD) | United States | $23.552B | 28.01 |
| Waters (WAT) | United States | $20.671B | 29.17 |
| SONOVA HOLDING (SONVY) | Switzerland | $19.948B | 0.00 |
| Hologic (HOLX) | United States | $12.216B | 13.27 |
| Sysmex ADR (SSMXY) | Japan | $10.569B | 29.98 |
| Penumbra (PEN) | United States | $10.471B | 82.18 |
| Masimo (MASI) | United States | $8.100B | 29.88 |
| Glaukos (GKOS) | United States | $5.418B | 0.00 |
| Teleflex (TFX) | United States | $5.390B | 8.90 |
| Integer Holdings (ITGR) | United States | $4.148B | 21.73 |
| TransMedics (TMDX) | United States | $4.103B | 89.20 |
| PROCEPT BioRobotics (PRCT) | United States | $3.134B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.381B | 14.18 |
| Veracyte (VCYT) | United States | $2.162B | 30.34 |
| Nihon Kohden (NHNKY) | Japan | $2.106B | 24.16 |
| Elekta AB (EKTAY) | Sweden | $2.050B | 18.43 |
| Alphatec Holdings (ATEC) | United States | $1.851B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.442B | 0.00 |
| Artivion (AORT) | United States | $1.219B | 114.20 |
| Pulse Biosciences (PLSE) | United States | $1.164B | 0.00 |
| OPKO Health (OPK) | United States | $1.031B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.986B | 5.24 |
| SiBone (SIBN) | United States | $0.815B | 0.00 |
| IRadimed (IRMD) | United States | $0.677B | 34.33 |
| Beta Bionics (BBNX) | United States | $0.675B | 0.00 |
| RxSight (RXST) | United States | $0.651B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.608B | 13.30 |
| Delcath Systems (DCTH) | United States | $0.600B | 0.00 |
| NeuroPace (NPCE) | United States | $0.595B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.587B | 9.14 |
| OrthoPediatrics (KIDS) | United States | $0.531B | 0.00 |
| AxoGen (AXGN) | United States | $0.519B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.501B | 13.32 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.449B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.396B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.389B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.340B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.294B | 0.00 |
| Neuronetics (STIM) | United States | $0.264B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.229B | 13.87 |
| Alpha Tau Medical (DRTS) | Israel | $0.219B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.171B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.167B | 0.00 |
| Accuray (ARAY) | United States | $0.167B | 0.00 |
| 908 Devices (MASS) | United States | $0.167B | 0.00 |
| LENSAR (LNSR) | United States | $0.165B | 0.00 |
| CVRx (CVRX) | United States | $0.163B | 0.00 |
| Inogen (INGN) | United States | $0.160B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.144B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.139B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.129B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.128B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.112B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.100B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.092B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.090B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.077B | 47.10 |
| InspireMD (NSPR) | Israel | $0.068B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.065B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.061B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.055B | 16.83 |
| Hyperfine (HYPR) | United States | $0.046B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.042B | 0.00 |
| Spectral AI (MDAI) | United States | $0.035B | 0.00 |
| Envoy Medical (COCH) | United States | $0.034B | 0.00 |
| Precision Optics (POCI) | United States | $0.032B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.032B | 0.00 | |
| DarioHealth (DRIO) | United States | $0.030B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.018B | 0.00 |
| NexGel (NXGL) | United States | $0.017B | 0.00 |
| PAVmed (PAVM) | United States | $0.011B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.010B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.009B | 0.00 |
| Tenon Medical (TNON) | United States | $0.009B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.008B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.006B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.001B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.001B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 17.03 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |